SSRIs have been prescribed in pregnancy for decades with research showing their relative safety. Updated studies indicate the benefits of SSRIs for managing maternal depression and anxiety surpass risks to the fetus. Untreated mental health conditions in pregnancy can lead to adverse outcomes, making it clear that the dangers of maternal depression outweigh those previously attributed to SSRIs. Although initial concerns involved side effects like neonatal adaptation syndrome, further research confirms that these medications do not increase the risk of miscarriage or birth defects compared to the general population.
Antidepressants in pregnancy have been studied extensively, more than most medications. Research shows that SSRIs have demonstrated relative safety, accumulating into the 30,000s.
Initial concerns linked SSRIs to neonatal adaptation syndrome (NAS), but advanced research has shown that untreated maternal depression or anxiety poses greater risks to infants.
The benefits of using SSRIs during pregnancy outweigh the risks, as untreated maternal mental health issues can lead to significant harm for both mother and child.
Ongoing debate around SSRIs in pregnancy persists despite evidence; studies find no increased risks of human miscarriages or birth defects with their use.
Collection
[
|
...
]